NCT00492037View on ClinicalTrials.gov

Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

PHASE3CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

January 31, 2000

Study Completion Date

February 28, 2002

Conditions
Hyponatremia
Interventions
DRUG

YM087 oral

Trial Locations (29)

Unknown

Brussels

Liège

Tournai

Jyväskylä

Turku

Garches

Limoges

Paris

Bad Nauheim

Berlin

Dresdan

Göttingen

München

Ferrara

Pavia

Pisa

Verona

Delft

Groningen

Leiden

Nijmegen

Radomsko

Warsaw

Wroclaw

Barcelona

Córdoba

Madrid

Cardiff

Manchester

Sponsors
All Listed Sponsors
collaborator

Parke-Davis

INDUSTRY

lead

Cumberland Pharmaceuticals

INDUSTRY